Sensitive. Efficient. Reliable.
The Agilent SARS-CoV-2 qRT-PCR Dx kit is a real-time reverse transcriptase PCR (qRT-PCR) in vitro diagnostic reagent kit for the qualitative detection of SARS-CoV-2 RNA. Clinical laboratories can easily generate diagnostic results from this single-tube assay. RNA is isolated and purified from nasopharyngeal, nasal, and oropharyngeal swab specimens1 obtained from individuals suspected of having COVID-19 by their healthcare provider.
The SARS-CoV-2 qRT-PCR Dx kit contains a primer and probe mix that targets the N1 and N2 regions of the SARS-CoV-2 nucleocapsid gene and human RNase P, and includes a synthetic SARS-CoV-2 RNA positive control. The kit is validated for use with multiple automated RNA extraction systems and real-time PCR instruments.
The Agilent SARS-CoV-2 qRT-PCR Dx kit has been designed for flexibility across the entire workflow. The open system has been validated with two commercially available RNA extraction products and three real-time PCR systems, including the AriaDx Real-Time PCR System*.